Phase 3 Randomized Low-Dose Paclitaxel Chemoradiotherapy Study for Locally Advanced Non-Small Cell Lung Cancer

Phase 3 Randomized Low-Dose Paclitaxel Chemoradiotherapy Study for Locally Advanced Non-Small Cell Lung Cancer

Introduction: Concurrent chemoradiotherapy (CCRT) is the standard treatment for locally advanced non-small cell lung cancer (LA-NSCLC), but is associated with poor chest tumor control. Here we report results of a randomized phase 3 study comparing two CCRT regimens in improving chest tumor control b...

Full description

Bibliographic Details
Main Authors: Hongmei Lin, Yuhchyau Chen, Anhui Shi, Kishan J Pandya, Rong Yu, Yannan Yuan, Jiancheng Li, Hang Li, Yingjie Wang, Tingyi Xia, Linchun Feng, Huimin Ma, Jianhao Geng, Guangying Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-12-01
Series:Frontiers in Oncology
Subjects:
Chemoradiotherapy
Paclitaxel
Non-small cell lung cancer
radiosensitization
Phase 3 trial
Online Access:http://journal.frontiersin.org/Journal/10.3389/fonc.2016.00260/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fonc.2016.00260/full

Similar Items